Phreesia ROA 2019-2024 | PHR
Phreesia ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2024-07-31 | $-0.10B | $0.36B | -27.32% |
2024-04-30 | $-0.12B | $0.37B | -32.94% |
2024-01-31 | $-0.14B | $0.37B | -38.36% |
2023-10-31 | $-0.15B | $0.38B | -40.31% |
2023-07-31 | $-0.15B | $0.34B | -41.89% |
2023-04-30 | $-0.16B | $0.35B | -42.15% |
2023-01-31 | $-0.18B | $0.37B | -42.62% |
2022-10-31 | $-0.18B | $0.40B | -41.44% |
2022-07-31 | $-0.18B | $0.43B | -37.74% |
2022-04-30 | $-0.16B | $0.46B | -30.89% |
2022-01-31 | $-0.12B | $0.49B | -21.92% |
2021-10-31 | $-0.08B | $0.53B | -16.06% |
2021-07-31 | $-0.05B | $0.55B | -11.25% |
2021-04-30 | $-0.03B | $0.56B | -9.24% |
2021-01-31 | $-0.03B | $0.33B | -10.95% |
2020-10-31 | $-0.02B | $0.34B | -11.25% |
2020-07-31 | $-0.02B | $0.16B | -11.32% |
2020-04-30 | $-0.08B | $0.16B | -51.96% |
2020-01-31 | $-0.09B | $0.16B | -76.99% |
2019-07-31 | $-0.10B | $0.16B | -242.94% |
2019-04-30 | $-0.04B | $0.00B | inf% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.252B | $0.356B |
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $11.978B | 0.00 |
Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
Axonics (AXNX) | United States | $3.602B | 1762.00 |
IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
Privia Health (PRVA) | United States | $2.736B | 228.00 |
Enovis (ENOV) | United States | $2.646B | 17.94 |
Omnicell (OMCL) | United States | $2.263B | 74.03 |
Azenta (AZTA) | United States | $2.242B | 127.33 |
10x Genomics (TXG) | United States | $1.925B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
Schrodinger (SDGR) | United States | $1.422B | 0.00 |
Standard BioTools (LAB) | United States | $0.830B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
Talkspace (TALK) | United States | $0.586B | 0.00 |
Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
Pulmonx (LUNG) | United States | $0.298B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
TruBridge (TBRG) | United States | $0.214B | 62.22 |
P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
American Well (AMWL) | United States | $0.139B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
HeartBeam (BEAT) | United States | $0.064B | 0.00 |
111 (YI) | China | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.050B | 0.00 |
Outset Medical (OM) | United States | $0.045B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
CareCloud (CCLD) | United States | $0.042B | 0.00 |
Movano (MOVE) | United States | $0.028B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |